GEN News Highlights: Jun 1, 2011

PeptLab to Aid Biotage in Development of Technologies for Peptides

(Page 1 of 1)

    The Laboratory of Peptide & Protein Chemistry & Biology (PeptLab) will contribute technical expertise toward future development of Biotage products. Under the agreement PeptLab will also provide training facilities for demonstrating the company’s peptide synthesis, purification, and resin offerings.

    PeptLab acquired Biotage’s Syro II and Syro Wave®, two fully automated parallel peptide synthesizers, for its SOSCO Laboratory. The equipment will significantly increase its peptide production, while the microwave heating capability of the Syro Wave will help provide access to more challenging peptides, according to PeptLab.

    Biotage produces tools and technologies for sample preparation, peptide synthesis, microwave synthesis, and flash purification. Biotage customers include pharmaceutical companies, NIH, CDC, and the Karolinska Institute. News of the collaboration with PeptLab emerged a week after Biotage announced two new positive pressure, solid-phase extraction platforms designed to reduce sample preparation time.


Related content

Subscription center

GEN MAGAZINE

Genetic Engineering & Biotechnology News (GEN) has retained its position as the most widely read biotechnology publication around the globe since its launch in 1981. Published 21 times a year and with additional exclusive editorial content online, GEN's unique news and technology focus includes the entire bioproduct life cycle from early-stage R&D, to applied research including omics, biomarkers, as well as diagnostics, to bioprocessing and commercialization.

Subscribe

e-NEWSLETTERS

Add GEN to your Inbox! Subscribe today to our complimentary e-newsletters and stay abreast of the latest biotech news and trends. Click the magnifying glass icon next to a newsletter title to view a sample.

 

All fields are required

Email
  Confirm Email
  First Name
  Last Name
  Organization
  E-Alert Format
 
 
  Sign Up

ADVERTISEMENT

ADVERTISEMENT

ADVERTISEMENT

GENpoll

Funding Early-Stage Companies

How much do you think newly established funds will succeed in helping startups?

Suggest a Poll